Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

Katz MHG et al. – Radiographic downstaging was rare after neoadjuvant therapy, and Response Evaluation Criteria in Solid Tumors (RECIST) response was not an effective treatment endpoint for patients with borderline resectable pancreatic cancer. The authors concluded that these patients should undergo pancreatectomy after initial therapy in the absence of metastases.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Family Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Family Medicine Articles

Indexed Journals in Family Medicine: American Family Physician, Archives of Family Med, Annals of Family Medmore